BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 27084889)

  • 1. Prokineticin receptor 1 is required for mesenchymal-epithelial transition in kidney development.
    Arora H; Boulberdaa M; Qureshi R; Bitirim V; Messadeq N; Dolle P; Nebigil CG
    FASEB J; 2016 Aug; 30(8):2733-40. PubMed ID: 27084889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prokineticin receptor-1 signaling promotes Epicardial to Mesenchymal Transition during heart development.
    Arora H; Boulberdaa M; Qureshi R; Bitirim V; Gasser A; Messaddeq N; Dolle P; Nebigil CG
    Sci Rep; 2016 May; 6():25541. PubMed ID: 27150455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prokineticin receptor 1 (PKR1) signalling in cardiovascular and kidney functions.
    Boulberdaa M; Urayama K; Nebigil CG
    Cardiovasc Res; 2011 Nov; 92(2):191-8. PubMed ID: 21856786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prokineticin receptor-1 (GPR73) promotes cardiomyocyte survival and angiogenesis.
    Urayama K; Guilini C; Messaddeq N; Hu K; Steenman M; Kurose H; Ert G; Nebigil CG
    FASEB J; 2007 Sep; 21(11):2980-93. PubMed ID: 17442730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prokineticin receptor-1 is a new regulator of endothelial insulin uptake and capillary formation to control insulin sensitivity and cardiovascular and kidney functions.
    Dormishian M; Turkeri G; Urayama K; Nguyen TL; Boulberdaa M; Messaddeq N; Renault G; Henrion D; Nebigil CG
    J Am Heart Assoc; 2013 Oct; 2(5):e000411. PubMed ID: 24152983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic inactivation of prokineticin receptor-1 leads to heart and kidney disorders.
    Boulberdaa M; Turkeri G; Urayama K; Dormishian M; Szatkowski C; Zimmer L; Messaddeq N; Laugel V; Dollé P; Nebigil CG
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):842-50. PubMed ID: 21273561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prokineticin receptor 1 as a novel suppressor of preadipocyte proliferation and differentiation to control obesity.
    Szatkowski C; Vallet J; Dormishian M; Messaddeq N; Valet P; Boulberdaa M; Metzger D; Chambon P; Nebigil CG
    PLoS One; 2013; 8(12):e81175. PubMed ID: 24324673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prokineticin receptor-1 induces neovascularization and epicardial-derived progenitor cell differentiation.
    Urayama K; Guilini C; Turkeri G; Takir S; Kurose H; Messaddeq N; Dierich A; Nebigil CG
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):841-9. PubMed ID: 18421008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Prokineticin Receptor-1 in Epicardial Progenitor Cells.
    Nguyen TL; Gasser A; Nebigil CG
    J Dev Biol; 2013 Jun; 1(1):20-31. PubMed ID: 33374490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic characterization of Wilms' tumor suppressor 1 targets in nephron progenitor cells during kidney development.
    Hartwig S; Ho J; Pandey P; Macisaac K; Taglienti M; Xiang M; Alterovitz G; Ramoni M; Fraenkel E; Kreidberg JA
    Development; 2010 Apr; 137(7):1189-203. PubMed ID: 20215353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergent roles of prokineticin receptors in the endothelial cells: angiogenesis and fenestration.
    Guilini C; Urayama K; Turkeri G; Dedeoglu DB; Kurose H; Messaddeq N; Nebigil CG
    Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H844-52. PubMed ID: 20023120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transcription factor Sry-related HMG box-4 (SOX4) is required for normal renal development in vivo.
    Huang J; Arsenault M; Kann M; Lopez-Mendez C; Saleh M; Wadowska D; Taglienti M; Ho J; Miao Y; Sims D; Spears J; Lopez A; Wright G; Hartwig S
    Dev Dyn; 2013 Jun; 242(6):790-9. PubMed ID: 23559562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WT1 in disease: shifting the epithelial-mesenchymal balance.
    Miller-Hodges E; Hohenstein P
    J Pathol; 2012 Jan; 226(2):229-40. PubMed ID: 21959952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PK2β ligand, a splice variant of prokineticin 2, is able to modulate and drive signaling through PKR1 receptor.
    Lattanzi R; Maftei D; Negri L; Fusco I; Miele R
    Neuropeptides; 2018 Oct; 71():32-42. PubMed ID: 30253862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prokineticin receptor-1-dependent paracrine and autocrine pathways control cardiac tcf21
    Qureshi R; Kindo M; Arora H; Boulberdaa M; Steenman M; Nebigil CG
    Sci Rep; 2017 Oct; 7(1):12804. PubMed ID: 29038558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WT1 is a modifier of the Pax2 mutant phenotype: cooperation and interaction between WT1 and Pax2.
    Discenza MT; He S; Lee TH; Chu LL; Bolon B; Goodyer P; Eccles M; Pelletier J
    Oncogene; 2003 Nov; 22(50):8145-55. PubMed ID: 14603255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor receptor-Frs2α signaling is critical for nephron progenitors.
    Di Giovanni V; Walker KA; Bushnell D; Schaefer C; Sims-Lucas S; Puri P; Bates CM
    Dev Biol; 2015 Apr; 400(1):82-93. PubMed ID: 25641696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LGR4 is required for the cell survival of the peripheral mesenchyme at the embryonic stages of nephrogenesis.
    Mohri Y; Oyama K; Sone M; Akamatsu A; Nishimori K
    Biosci Biotechnol Biochem; 2012; 76(5):888-91. PubMed ID: 22738954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prokineticin receptors in cardiovascular function: foe or friend?
    Nebigil CG
    Trends Cardiovasc Med; 2009 Feb; 19(2):55-60. PubMed ID: 19577713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WT1 targets Gas1 to maintain nephron progenitor cells by modulating FGF signals.
    Kann M; Bae E; Lenz MO; Li L; Trannguyen B; Schumacher VA; Taglienti ME; Bordeianou L; Hartwig S; Rinschen MM; Schermer B; Benzing T; Fan CM; Kreidberg JA
    Development; 2015 Apr; 142(7):1254-66. PubMed ID: 25804736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.